Rankings
▼
Calendar
AMRN Q1 2025 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$310M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$42M
-25.7% YoY
Gross Profit
$25M
59.8% margin
Operating Income
-$17M
-39.9% margin
Net Income
-$16M
-37.4% margin
EPS (Diluted)
$-0.76
QoQ Revenue Growth
-32.6%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$656M
Total Liabilities
$182M
Stockholders' Equity
$474M
Cash & Equivalents
$120M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$42M
$57M
-25.7%
Gross Profit
$25M
$32M
-21.2%
Operating Income
-$17M
-$14M
-23.4%
Net Income
-$16M
-$10M
-57.7%
Revenue Segments
Product
$41M
98%
Licensing And Royalty
$982,000
2%
Geographic Segments
UNITED STATES
$36M
87%
Europe
$5M
13%
← FY 2025
All Quarters
Q2 2025 →